| 1 |
32722075 | Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells. | 2020 Jul 24 |
1 |
| 2 |
30628639 | Long non‑coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway. | 2019 Mar |
1 |
| 3 |
27432642 | Berberine enhances the anti‑tumor activity of tamoxifen in drug‑sensitive MCF‑7 and drug‑resistant MCF‑7/TAM cells. | 2016 Sep |
1 |
| 4 |
25595558 | Sp1 regulates Raf/MEK/ERK-induced p21(CIP1) transcription in TP53-mutated cancer cells. | 2015 Mar |
1 |
| 5 |
23361053 | Regulation of tamoxifen sensitivity by a PAK1-EBP1 signalling pathway in breast cancer. | 2013 Feb 19 |
1 |
| 6 |
21922150 | Effect of combined treatment with progesterone and tamoxifen on the growth and apoptosis of human ovarian cancer cells. | 2012 Jan |
1 |
| 7 |
22589186 | Proteomic identification of E6AP as a molecular target of tamoxifen in MCF7 cells. | 2012 May |
1 |
| 8 |
20086099 | 14-3-3Tau regulates ubiquitin-independent proteasomal degradation of p21, a novel mechanism of p21 downregulation in breast cancer. | 2010 Mar |
2 |
| 9 |
19276356 | FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus. | 2009 Mar 15 |
1 |
| 10 |
14633737 | Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens. | 2003 Nov 15 |
1 |
| 11 |
10661763 | Characterization of a human melanoma cell line with non-oestrogen receptor dependent tamoxifen resistance. | 1999 Dec |
2 |
| 12 |
9199341 | Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. | 1997 Jul |
1 |